Replies to post #167046 on Avid Bioservices Inc (CDMO)

[geocappy1]

Is it possible that the buyers of those 16M shares @ $1.75 ($27M) are the same buyers who bought the preferred shares at $20M. Total investment $47M. Then they turn around and sell those original 16M shares at say $2.90 in the following weeks as part of the 100M shares sold. They realize 2.90x16M or about $47M for a net cost of $0 and they still hold the preferred. Run the ATM at $1.75, place a $20M preferred offering, schedule a bunch of conferences (both investor and science) which release a whole bunch of milk toast data (sure an unusual amount of conferences with no wow factor). Voila, prearranged financing at no cost to the big investor.

Like EBS says, if no form 13s and no earth shattering news, one has to wonder what it was all about. Is the market figuring it out or is this just natural ebb and flow.

[Frustrated]

And when Feb. 15 came and went with no updated form 13s, again...it made very little sense to me. How could 20 million new shares be issued in a month, 115 million shares trade in February not trigger an SEC reporting requirement? I don't buy into the secret family buying theories, but then another thought crossed my mind that stemmed from the change in King's dialogue from partnership to "collaboration".

In the past Lytle and company would say they sold the pipes to strong investor institutions yet they never showed up on the institution reports. With the shady history of the BOD members and their ties to each other prove nothing is impossible. All imo.